Can Calcium Supplements Cause Plaque in Arteries?

Calcium supplements may contribute to calcium buildup in artery walls, though the effect is modest and the evidence is more nuanced than a simple yes or no. Several meta-analyses of randomized trials have found that calcium supplements slightly raise the risk of heart attacks and cardiovascular events, and at least one imaging study has linked supplement use to increasing coronary calcification over time. Yet dietary calcium from food does not carry the same signal, and factors like vitamin K status, magnesium intake, and kidney function all influence whether extra calcium ends up in your bones or your blood vessels.

How Calcium Gets Into Artery Walls

Calcium deposits in arteries are not just passive mineral buildup from having too much calcium floating around in the blood. The process is actively driven by cells in the artery wall. Smooth muscle cells that normally keep blood vessels flexible can transform into bone-like cells under the right conditions, producing a scaffold of proteins that attracts calcium and phosphate and locks them into the vessel wall.

This transformation is the same basic process that builds bone, just happening in the wrong place. The smooth muscle cells generate tiny packets called matrix vesicles that serve as seeds for calcium-phosphate crystals to form on.

¹ Inflammation, high phosphate levels, oxidative stress, and aging all push vascular cells toward this bone-like behavior. Once calcification starts, it tends to progress.

When calcium intake is high over long periods, the body can only deposit so much of the surplus into bone. The concern researchers have raised is that the extra retained calcium may end up in soft tissues and in pre-existing atherosclerotic plaques rather than strengthening the skeleton. If that hypothesis holds, excess calcium loading could accelerate the hardening and narrowing of arteries.

What the Clinical Evidence Shows

The most influential analysis linking calcium supplements to cardiovascular harm was a 2010 meta-analysis published in the BMJ. Pooling patient-level data from five trials, it found that people assigned to calcium supplements had about a 31% higher rate of heart attack compared with placebo. When the researchers broadened the analysis to include trial-level data from additional studies, the increase was around 27%.

³ Those numbers sound dramatic, but the absolute risk increase was small because heart attacks were uncommon in these trial populations to begin with.

A later meta-analysis of 14 double-blind, placebo-controlled randomized trials found calcium supplements raised the risk of cardiovascular disease by about 15% and coronary heart disease by about 16%, with the clearest signal in healthy postmenopausal women. In a subgroup analysis, the risk appeared when dietary calcium was already in the range of 700 to 1,000 mg per day and supplemental calcium added another 1,000 mg on top of that.

⁴

On the imaging side, a study using intravascular ultrasound found that calcium supplementation was independently associated with increases in coronary calcification over time, with roughly 15% higher odds of calcification progressing even after accounting for other risk factors and changes in plaque volume.

⁵

Not every study agrees, though. The Framingham Offspring Study looked at coronary artery calcium scores across different levels of calcium intake and found no significant trend. Mean calcification scores were similar whether people consumed low or high amounts of total, dietary, or supplemental calcium, and neither women nor men showed a meaningful association.

⁶ This contradiction is part of what keeps the debate alive. The Framingham results are observational and measured calcium scores at a single point, while the intravascular ultrasound study tracked changes over time. Different study designs can reach different conclusions, and neither is definitively wrong.

Why Dietary Calcium Seems Safer

One of the more consistent patterns in the research is that calcium from food does not carry the same cardiovascular signal as calcium from pills. Most meta-analyses that flag a risk are specifically about supplements, not about eating calcium-rich foods. The Framingham data showed no association between dietary calcium intake and coronary calcification scores.

⁶

The leading explanation centers on how fast calcium hits the bloodstream. When you take a 500 or 1,000 mg calcium tablet, you absorb a large dose over a short window, creating a temporary spike in serum calcium. When you eat a bowl of yogurt or a serving of kale, the calcium is released more gradually as the food is digested, and the peak serum level is lower. That spike matters because a sudden rise in blood calcium can overwhelm the body’s normal regulatory machinery and, in theory, promote mineral deposition in places it does not belong.

Calcium-fortified foods complicate this picture. Research comparing calcium citrate supplements to calcium-fortified orange juice found that the fortified juice raised serum calcium to similar levels as the supplement, while a dairy-based meal produced a smaller and more gradual rise.

⁷ That finding suggests fortified foods may behave more like supplements than like whole-food sources, at least in how sharply they raise serum calcium. Whether that translates into a cardiovascular risk remains unclear, but it is worth keeping in mind if you are reaching for fortified juice as a supposedly gentler alternative to pills.

⁸

The Formulation You Choose Matters

Calcium supplements come in different chemical forms, and they are not equally absorbed. Calcium citrate is substantially more bioavailable than calcium carbonate. In a pharmacokinetic comparison, calcium citrate produced a rise in serum calcium that was roughly two and a half times greater in total absorption and about 76% higher at peak levels than calcium carbonate. Calcium carbonate barely outperformed a placebo across most time periods.

⁹

This has practical implications for the vascular calcification question. If the serum calcium spike is the mechanism that promotes arterial calcium deposits, then a more bioavailable supplement could, in principle, pose more risk per dose. On the other hand, calcium carbonate requires stomach acid for absorption and is typically taken with meals, which somewhat blunts the spike. Calcium citrate can be taken on an empty stomach, which is more convenient but also means the calcium enters the bloodstream faster and without the buffering effect of food. Neither form has been isolated as definitively safer or riskier for the cardiovascular system in clinical trials, but the pharmacokinetic differences are real and may eventually help explain some of the conflicting study results.

Vitamin K and Magnesium as Protective Factors

The body has natural defense systems that keep calcium out of soft tissues, and two nutrients play especially important roles. Vitamin K is essential for activating proteins that inhibit vascular calcification. Matrix Gla protein, or MGP, is one of the strongest natural inhibitors of calcium buildup in blood vessels, but it only works when vitamin K activates it through a process called carboxylation.

¹⁰ Without adequate vitamin K, MGP sits around in its inactive form, and the brakes on vascular calcification are effectively off.

¹¹

Magnesium works through a different mechanism. Lab and animal research shows that magnesium directly blocks the formation of hydroxyapatite, the crystalline form of calcium-phosphate that makes up arterial calcification deposits. In one study, magnesium reduced the calcium fraction of extracellular crystals by about 68% and the phosphate fraction by about 41%.

¹² Magnesium also appears to limit the transformation of smooth muscle cells into bone-like cells, attacking the problem from a second angle.

¹³

Most of the magnesium evidence comes from cell cultures and animal models rather than large human trials, so the strength of the protective effect in people is not fully quantified. Still, the mechanistic evidence is strong enough that some researchers have speculated that a person who takes calcium supplements while being low in vitamin K or magnesium could be in a particularly bad position: extra calcium coming in with weakened defenses against misplaced deposition. That is a plausible hypothesis, not a proven one, but it does suggest that looking at calcium supplementation in isolation from the rest of the diet may miss part of the picture.

Does Adding Vitamin D Help?

Many people take calcium alongside vitamin D, partly because vitamin D improves calcium absorption and partly because combined supplements are widely marketed for bone health. Whether the addition of vitamin D modifies the cardiovascular risk is a question the research has struggled with.

A reanalysis of the Women’s Health Initiative data, combined with a meta-analysis of placebo-controlled trials, found that calcium with vitamin D still increased the risk of heart attack by about 21% and the combined risk of heart attack or stroke by about 16%. The authors concluded that calcium supplements, with or without vitamin D, modestly raise cardiovascular event risk.

¹⁴

A more recent population-based cohort study, however, found a sharp distinction between calcium taken alone and calcium taken with vitamin D. Calcium-only supplementation was associated with about a 21% higher risk of recurrent cardiovascular events in people who already had cardiovascular disease. The combination of calcium and vitamin D, by contrast, showed essentially no increased risk. The difference was seen in both men and women, though the calcium-only risk was somewhat more pronounced in men.

¹⁵

These findings appear to conflict, and the honest answer is that they do. The BMJ reanalysis pooled data from randomized controlled trials, while the cohort study used observational data. Observational studies can be confounded by factors like healthier behavior among people who choose to take vitamin D. The trial evidence, which is generally more reliable for determining cause and effect, still suggests the combination raises risk. This is one of the genuinely unresolved questions in the field.

Kidney Disease Changes the Equation

For people with chronic kidney disease, the vascular calcification concern goes from theoretical to well-documented. Failing kidneys cannot properly excrete phosphate, so phosphate levels in the blood climb. At the same time, patients are often given calcium-based phosphate binders to control those phosphate levels. The combination of high phosphate and extra oral calcium creates a perfect storm for vascular calcification.

Randomized trials comparing calcium-based binders to non-calcium alternatives have found that the calcium-based binders contribute to progressive calcification in the coronary arteries and aorta.

¹⁶ In one head-to-head trial, patients taking calcium acetate showed significant increases in aortic calcification scores at both six months and one year, while those taking the non-calcium binder sevelamer did not progress significantly.

¹⁷

This is one area where the evidence is strong enough that clinical practice has shifted. Many nephrology guidelines now recommend limiting calcium-based phosphate binders and preferring alternatives, especially in patients who already have evidence of vascular calcification. If you have significant kidney disease and are taking any calcium-containing medication, the conversation with your nephrologist about vascular calcification risk is worth having explicitly.

Micro vs. Macro Calcification in Arteries

Not all arterial calcification is created equal, and this is a subtlety that often gets lost in the public conversation. Large, dense calcium deposits in artery walls, called macrocalcifications, are common with aging and are readily visible on CT scans. They are a marker of longstanding atherosclerosis, but they are not necessarily the most dangerous type. In fact, some researchers view large stable calcified plaques as less likely to rupture than softer, non-calcified ones.

Spotty microcalcifications are a different story. These tiny calcium deposits, detectable with advanced imaging like intravascular ultrasound or optical coherence tomography, are strongly associated with plaque instability.

¹⁸ Unstable plaques are the ones that can rupture and trigger a heart attack. The distinction matters because a coronary artery calcium score from a standard CT scan mostly captures macrocalcification, which means a high score indicates atherosclerosis burden but does not necessarily mean the plaques are about to cause an event. Meanwhile, the more dangerous microcalcifications can exist in arteries with relatively low overall calcium scores.

This is relevant to the supplement question because the imaging study linking calcium supplements to progressive coronary calcification used intravascular ultrasound, which captures changes that standard CT scans might miss.

⁵ Whether supplement-driven calcification tends to produce the more dangerous microcalcification pattern or the more benign macrocalcification pattern is something the current evidence cannot fully answer. But the distinction is a reminder that “more calcium in the arteries” is not a single phenomenon with a single risk profile.

Who Is Most and Least at Risk

The cardiovascular signal from calcium supplements has been clearest in a few specific groups. Healthy postmenopausal women, who are also the population most commonly advised to take calcium for bone health, show the most consistent risk elevation in meta-analyses.

⁴ People with existing cardiovascular disease who take calcium-only supplements also appear to have higher recurrence risk.

¹⁵ And as discussed above, people with chronic kidney disease face an amplified version of the problem.

For younger adults with normal kidney function and no cardiovascular disease, the evidence is much thinner. Most trials enrolled older women, so the data simply do not exist to say with confidence whether calcium supplements pose a meaningful vascular risk in, say, a 35-year-old man or a premenopausal woman. The risk, if any, is likely smaller in people whose arteries are healthier to begin with, since pre-existing plaque provides a surface for calcium to deposit onto.

The Women’s Health Initiative, which was the largest trial to examine calcium and vitamin D supplementation, found that the overall health benefits and risks were roughly balanced, including a modest increase in kidney stone formation.

¹⁹ That “approximately balanced” conclusion is a fair summary of where the science sits for the general population: the bone benefits of supplementation are real but modest, and so are the potential cardiovascular harms. For someone whose dietary calcium intake already meets recommended levels, adding a supplement tilts the balance toward risk with little extra bone benefit. For someone with genuinely low dietary intake and no easy way to fix it through food, the calculus is different and more individual.

Practical Steps if You Take Calcium Supplements

If you are currently taking calcium supplements and wondering what to do, a few practical considerations emerge from the research:

Prioritize food sources: Dairy, leafy greens, canned fish with bones, and fortified plant milks deliver calcium without the sharp serum spikes associated with supplement tablets. Be aware, though, that some fortified products produce serum calcium rises similar to supplements.
Split doses: If you take supplements, smaller doses taken at separate times of day are absorbed better and produce lower peak serum levels than a single large tablet.
Take with meals: Eating food alongside a supplement slows absorption and reduces the spike, which may lower the risk of calcium being deposited in the wrong tissues.
Watch total intake: The risk signal in meta-analyses appeared most clearly when supplemental calcium of about 1,000 mg per day was added on top of a diet already providing 700 to 1,000 mg. If your diet is already calcium-adequate, supplementation may be adding risk for minimal bone benefit.
Ensure adequate vitamin K and magnesium: Both nutrients support the body’s mechanisms for keeping calcium out of arteries. Green vegetables supply vitamin K; nuts, seeds, and whole grains supply magnesium.

These strategies are sensible extrapolations from the available evidence, not guarantees. No trial has tested whether splitting doses or adding magnesium specifically prevents supplement-driven vascular calcification. But each aligns with what the mechanistic and observational evidence suggests, and none carries meaningful downside risk.

1
PubMed Central. Vascular calcification: Mechanisms of vascular smooth muscle cell calcification
2
PubMed Central. Risk of High Dietary Calcium for Arterial Calcification in Older Adults – Section: Physiological Mechanisms
3
BMJ. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis
4
PubMed Central. Calcium Supplements and Risk of Cardiovascular Disease: A Meta-Analysis of Clinical Trials
5
PubMed. Oral Calcium Supplements Associate With Serial Coronary Calcification: Insights From Intravascular Ultrasound
6
The American Journal of Clinical Nutrition. Calcium Intake from Diet and Supplementation and the Risk of Coronary Artery Calcification in the Framingham Study
7
PubMed. Acute effects of calcium citrate with or without a meal, calcium-fortified juice and a dairy product meal on serum calcium and phosphate: a randomised cross-over trial
8
Maturitas. Calcium fortified foods or supplements for older people?
9
PubMed. Pharmacokinetics of calcium absorption from two commercial calcium supplements
10
Advances in Nutrition. The Role of Vitamin K in Soft-Tissue Calcification
11
Trends in Molecular Medicine. Molecular mechanisms of vascular mineralization
12
PubMed Central. Magnesium prevents vascular calcification in vitro by inhibition of hydroxyapatite crystal formation
13
PubMed Central. Magnesium and Vascular Calcification in Chronic Kidney Disease: Current Insights
14
BMJ. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis
15
PubMed Central. Association Between Calcium Supplementation and Recurrence of Cardiovascular Events in Patients With Cardiovascular Disease: A Population-Based Cohort Study
16
Clinical Journal of the American Society of Nephrology. The Case against Calcium-Based Phosphate Binders
17
Nephro-Urology Monthly. A Comparison Between the Effects of Calcium Acetate and Sevelamer Carbonate on Progression of Aortic Vascular Calcification in Patients with Chronic Kidney Disease Stages 4 and 5
18
PubMed Central. Coronary Artery Microcalcification: Imaging and Clinical Implications
19
PubMed Central. Health risks and benefits from calcium and vitamin D supplementation: Women’s Health Initiative clinical trial and cohort study